Examine Key Factors Influencing Gene Therapy Future Development

Research and Markets (http://www.researchandmarkets.com/reports/c41267) has announced the addition of "Gene Therapy - Global Strategic Business Report" to their offering.

This report analyzes the worldwide markets for Gene Therapy in Millions of US$. The report provides separate comprehensive analytics for the US, Europe, and Rest of World. Annual forecasts are provided for each region for the period of 2005 through 2010. The report profiles 98 companies including many key and niche players worldwide such as AnGes MG Inc, Athersys Inc, Avigen, Canji Inc, Cell Genesys, Centelion SA, GenVec, Genzyme Corporation, Introgen Therapeutics Inc, Oxford BioMedica, Shenzhen SiBiono GeneTech Co., Ltd, Targeted Genetics Corp, Transgene, Valentis Inc., and Vical.

Key Topics Covered Include:

-- Market Dynamics

-- Key Issues/ Trends

-- The Global Landscape

-- Gene Therapy

-- Components of Gene Therapy

-- Review of Various Approaches

-- Gene Therapy For Disease Treatment

-- Regulatory Environment

-- Research and Development

-- Recent Industry Activity

-- Focus on Key Players

-- Global Market Perspective

Other Companies Mentioned Include:

-- Biophan Technologies, Inc (USA)

-- Biophoenix (UK)

-- BioProtein Technologies (France)

-- Biosense Webster, Inc (USA)

-- BioVex Ltd (UK)

-- Celera Genomics Group (USA)

-- Cell Genesys, Inc (USA)

-- Celltech Group PLC (UK)

-- Celsion Corporation (USA)

-- Centelion (France)

-- CereGene, Inc (USA)

-- Cobra Biomanufacturing PLC (UK)

-- Copernicus Therapeutics, Inc (USA)

-- Corixa Corporation (USA)

-- Cosmo SpA (Italy)

-- Cosmo Bioscience, Inc (USA)

-- Crucell NV (The Netherlands)

-- Cyclacel Limited (UK)

-- Cygene Laboratories (USA)

-- Cytogen Corporation (USA)

-- CytRx Corporation (USA)

-- DeveloGen AG (Germany)

-- Diversa Corporation (USA)

-- Enzo Biochem, Inc (USA)

-- Fit Biotech Oyj PLC (Finland)

-- Gene Therapy Systems, Inc (USA)

-- GeneCure LLC (USA)

-- GenEra SpA (Italy)

-- Genetix Pharmaceuticals, Inc (USA)

-- Genteric, Inc (USA)

-- GenVec, Inc (USA)

-- Genzyme Corporation (USA)

-- Genzyme Molecular Oncology (USA)

-- Genzyme Therapeutics (UK)

-- Geron Corporation (USA)

-- Gilead Sciences, Inc (USA)

-- Glygen Corporation (USA)

-- GTx, Inc (USA)

-- Guidant Corporation (USA)

-- Human Genome Sciences, Inc (USA)

-- ImGenex Corporation (USA)

-- Immusol, Inc (USA)

-- Innovata Plc (U K)

-- Introgen Therapeutics, Inc (USA)

-- Intronn LLC (USA)

-- Invitrogen Corporation (USA)

-- InvivoGen (USA)

-- MaxCyte (USA)

-- Merck KGAA (Germany)

-- Mitsubishi Chemical Corporation (Japan)

-- MolMed SpA (Italy)

-- Northwest Biotherapeutics, Inc (USA)

-- Novartis AG (Switzerland)

-- NsGENE A/S (Denmark)

-- Onyx Pharmaceuticals, Inc (USA)

-- OSI Pharmaceuticals, Inc (USA)

-- Osiris Therapeutics, Inc (USA)

-- Oxford BioMedica PLC (UK)

-- Oxxon Therapeutics Ltd (UK)

-- Qugen Therapeutics Pte, Ltd (Singapore)

-- RheoGene, Inc (USA)

-- Sanofi-Aventis (France)

-- Sanofi Aventis Pharmaceuticals, Inc (USA)

For more information visit http://www.researchandmarkets.com/reports/c41267

Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here